Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study (Q37368518)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 2009

Language	Label	Description	Also known as
English	Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study	scientific article published on October 2009

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study (English)

1 reference

Europe PubMed Central

20 August 2017

author name string

John F Kuttesch

1

1 reference

Europe PubMed Central

20 August 2017

Mark D Krailo

2

1 reference

Europe PubMed Central

20 August 2017

Timothy Madden

3

1 reference

Europe PubMed Central

20 August 2017

Mary Johansen

4

1 reference

Europe PubMed Central

20 August 2017

Archie Bleyer

5

1 reference

Europe PubMed Central

20 August 2017

Children's Oncology Group

6

1 reference

Europe PubMed Central

20 August 2017

publication date

1 October 2009

1 reference

Europe PubMed Central

20 August 2017

Pediatric Blood Cancer

1 reference

Europe PubMed Central

20 August 2017

53

1 reference

Europe PubMed Central

20 August 2017

4

1 reference

Europe PubMed Central

20 August 2017

590-593

1 reference

Europe PubMed Central

20 August 2017

A retrospective analysis of vinorelbine chemotherapy for patients with previously treated soft-tissue sarcomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

6 September 2017

Vinorelbine in previously treated advanced childhood sarcomas: evidence of activity in rhabdomyosarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

6 September 2017

A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

6 September 2017

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

6 September 2017

Phase I pharmacologic study of a new Vinca alkaloid: navelbine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

6 September 2017

A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

6 September 2017

RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

14 September 2017

Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

14 September 2017

Multidrug resistance in pediatric oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

28 September 2017

Confidence intervals following group sequential tests.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

26 June 2018

Designs for group sequential phase II clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

26 June 2018

Efficacy of Navelbine (NVB) in non-small cell lung cancer (NSCLC).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

26 June 2018

A case of relapsing glioblastoma multiforme responding to vinorelbine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

2 September 2018

Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

2 September 2018

Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

2 September 2018

Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

2 September 2018

The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

2 September 2018

Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

2 September 2018

Phase-II study of Navelbine in advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754403

2 September 2018

Biochemical effects of Navelbine on tubulin and associated proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/19533657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19533657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules

1 reference

https://pubmed.ncbi.nlm.nih.gov/19533657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19533657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/PBC.22133

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37368518&oldid=1702624094"